peroxynitrous acid has been researched along with formazans in 2 studies
Studies (peroxynitrous acid) | Trials (peroxynitrous acid) | Recent Studies (post-2010) (peroxynitrous acid) | Studies (formazans) | Trials (formazans) | Recent Studies (post-2010) (formazans) |
---|---|---|---|---|---|
3,303 | 21 | 1,230 | 1,206 | 2 | 230 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cassiman, D; Fevery, J; Libbrecht, L; Nevens, F; Roskams, T; Severi, T; van Pelt, JF; VanAelst, L; Vander Borght, S; Verslype, C | 1 |
Chen, SP; Chen, WL; Guan, YY; Lin, YC; Liu, J; Meng, WF; Pang, JY; Pei, Z; Qian, Y; Wang, GL | 1 |
2 other study(ies) available for peroxynitrous acid and formazans
Article | Year |
---|---|
HBx or HCV core gene expression in HepG2 human liver cells results in a survival benefit against oxidative stress with possible implications for HCC development.
Topics: Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Survival; Formazans; Hepatitis C Antigens; Humans; Hydrogen Peroxide; Liver; Liver Neoplasms; Microscopy, Fluorescence; Oxidation-Reduction; Oxidative Stress; Peroxynitrous Acid; Trans-Activators; Transfection; Viral Regulatory and Accessory Proteins | 2007 |
A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro.
Topics: Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Vascular; Fluoresceins; Fluorescent Dyes; Formazans; Humans; Indoles; Lipoproteins, LDL; Molecular Structure; NADPH Oxidases; Nitric Oxide; Oxidation-Reduction; Peroxynitrous Acid; Pyrans; Reactive Oxygen Species; Tetrazolium Salts; Time Factors; Tyrosine; Umbilical Veins; Xylariales | 2009 |